Candriam Equities L Biotech.I EUR Acc/ LU1120766032 /
| NAV5/25/2023 | Chg.-31.1300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,012.0200EUR | -1.52% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | - | - | - | - | - | - | - | -11.00 | 9.00 | 8.02 | -2.36 | - |
| 2016 | -22.88 | -4.93 | -1.29 | 3.06 | 8.39 | -8.04 | 11.86 | -2.02 | 2.94 | -10.16 | 12.33 | -2.27 | -17.28% |
| 2017 | 2.99 | 8.66 | -0.73 | -0.63 | -6.06 | 7.75 | -0.77 | 5.59 | 1.39 | -4.99 | -2.01 | 0.83 | +11.43% |
| 2018 | 2.97 | -2.64 | -2.70 | -1.36 | 8.35 | 0.97 | 4.46 | 4.80 | -1.85 | -11.78 | 4.28 | -9.24 | -5.57% |
| 2019 | 12.84 | 4.24 | 0.92 | -4.67 | -4.18 | 7.07 | -0.09 | -1.27 | -3.22 | 7.98 | 13.15 | 0.65 | +36.28% |
| 2020 | -3.94 | -0.26 | -4.88 | 13.11 | 7.67 | 0.44 | -7.71 | -0.21 | 2.72 | -2.15 | 6.96 | 0.76 | +11.20% |
| 2021 | 2.61 | -2.43 | -1.06 | 0.36 | -3.34 | 9.33 | -1.38 | 4.46 | -2.39 | 0.38 | -1.61 | 1.44 | +5.86% |
| 2022 | -9.49 | -2.17 | 6.73 | -2.56 | -4.79 | 5.58 | 7.26 | 2.53 | 0.67 | 6.00 | 1.92 | -6.17 | +3.88% |
| 2023 | 1.21 | -3.40 | -1.97 | 0.66 | 1.77 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 17.99% | 19.11% | 22.87% | 22.33% | 24.16% |
| Sharpe ratio | -0.45 | -0.64 | 0.57 | -0.02 | 0.20 |
| Best month | +1.77% | +1.92% | +7.26% | +9.33% | +13.15% |
| Worst month | -6.17% | -6.17% | -6.17% | -9.49% | -11.78% |
| Maximum loss | -9.35% | -13.42% | -13.42% | -20.59% | -26.96% |
| Outperformance | -3.12% | - | -0.76% | - | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,849.3000 | +17.19% | +7.28% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 201.1700 | +16.65% | - | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,892.9100 | +13.01% | +0.38% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,012.0200 | +16.45% | +9.43% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,148.6499 | +18.86% | +6.00% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 330.0800 | +20.23% | +8.68% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 294.1000 | +17.67% | +11.05% | |
| Candriam Equities L Biotech.R CH... | reinvestment | 188.6300 | +12.99% | +0.43% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,650.5601 | +18.51% | - | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,065.0400 | +16.94% | +6.92% | |
| Candriam Equities L Biotech.V US... | reinvestment | 544.6700 | +16.75% | +4.50% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 182.3600 | +13.95% | -0.34% | |
| Candriam Equities L Biotech.R US... | reinvestment | 239.8400 | +18.21% | +8.47% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 188.5600 | +14.24% | +2.02% | |
| Candriam Equities L Biotech.C US... | reinvestment | 761.7800 | +17.24% | +5.93% | |
| Candriam Equities L Biotech.C US... | paying dividend | 699.9700 | +17.20% | +5.82% |
Performance
| YTD | -1.82% | ||
|---|---|---|---|
| 6 Months | -4.49% | ||
| 1 Year | +16.45% | ||
| 3 Years | +9.43% | ||
| 5 Years | +48.78% | ||
| 10 Years | - | ||
| Since start | +34.13% | ||
| Year | |||
| 2022 | +3.88% | ||
| 2021 | +5.86% | ||
| 2020 | +11.20% | ||
| 2019 | +36.28% | ||
| 2018 | -5.57% | ||
| 2017 | +11.43% | ||
| 2016 | -17.28% | ||